Oral Cancer in East Africa: The Need for Early Detection
Did you know that oral cancer is a topical public health issue in East Africa? This article provides a comprehensive analysis of oral cancer in East Africa, covering epidemiology, awareness, risk factors, and clinical outcomes. The findings emphasise a growing public health concern, with tobacco ...
Engineering Resilience: Mastering Pharma Patent Expiration Strategy
The recent decision by Novartis to lay off 427 employees in New Jersey highlights a persistent challenge in the pharmaceutical industry: the looming threat of
Improving Diabetes Medicine Access: Key Changes in the Pharmaceutical Benefits Scheme
The Pharmaceutical Benefits Scheme (PBS) recently updated restrictions on type 2 diabetes mellitus (T2DM) medicines. The changes aim to improve clarity and simplify diabetes medicine access while aligning with clinical guidelines and ensuring cost-effectiveness. Notably, on April 1, 2025, empagli...
HPV Testing in Head and Neck Squamous Cell Carcinoma
Are you up to date with the latest advancements in Human Papillomavirus (HPV) testing for head and neck cancer? This article highlights the importance of accurately determining
Early Benefit Assessment of Tislelizumab NSCLC Treatment: Insights and Implications
The German Federal Joint Committee (G-BA) has initiated an early benefit assessment for tislelizumab NSCLC treatment. It's used as monotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) following platinum-based chemotherapy. This assessment is based ...
